EUVIMEDEUVIMED entdecken
Crossref

A Missed Opportunity? Osteoporosis Treatment Following Femoral Neck Fractures: Reducing the Risk of Secondary Hip Fracture

Elizabeth Rieger, Andrew Fuqua, Alyssa Woltemath, Jacob M Wilson, Christian Pean, Alejandro Gonzalez Della Valle, Ajay Premkumar

The Journal of Arthroplasty · 2026-03 · 41 (3) · 781-788.e3

DOI: 10.1016/j.arth.2025.07.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2026-03. Verfasst von Elizabeth Rieger und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, Georgia. Hauptthemen laut MEDLINE: Femoral Neck Fractures, Osteoporosis, Hip Fractures, Bone Density Conservation Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hip fractures represent devastating injuries with extensive morbidity and mortality. Despite guidelines recommending osteoporosis pharmacotherapy after hip fracture, treatment rates remain low. This study sought to determine the effect of osteoporosis pharmacotherapy on the secondary hip fracture rate in patients undergoing operative treatment for femoral neck fracture (FNFx). METHODS: A large national database was queried for patients ≥ 50 years old who underwent operative fixation of FNFx between 2009 and 2022. Age, sex, comorbidities, and pharmaceutical records were collected from the database. Among the 17,128 study patients, the mean age was 79 years (range, 50 to 103), and 65% were women. Patients previously treated for osteoporosis were excluded. Kaplan-Meier and Cox proportional hazards analyses were used to compare secondary hip fracture rates in patients who were medically treated for osteoporosis within one year of index FNFx versus those who were never treated for osteoporosis. Cumulative rates of osteoporosis pharmacotherapy initiation and secondary hip fracture were determined. RESULTS: Treatment initiation within one year was associated with a significantly reduced hip fracture hazard at three years (hazard ratio [HR]: 0.56, 95% confidence interval [CI]: 0.32 to 0.95, P = 0.03), five years (HR: 0.63, 95% CI: 0.40 to 0.98, P = 0.04), and 10 years (HR: 0.57, 95% CI: 0.37 to 0.87, P = 0.01) following FNFx. Only 6.3% of study patients were initiated on osteoporosis medication within one year following FNFx. The cumulative rate of secondary hip fracture over 10 years was 5.3%. CONCLUSIONS: Despite established guidelines, low rates of osteoporotic pharmacotherapy were seen in patients who had FNFx. Pharmacotherapy initiation within one year of FNFx was associated with a reduced rate of secondary hip fracture. In adherence to guidelines, physicians should educate patients and initiate osteoporosis treatment along with operative management of FNFx, given its association with reduced rates of subsequent hip fractures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Femoral Neck FracturesOsteoporosisHip FracturesBone Density Conservation AgentsOsteoporotic FracturesHumansFemaleAgedMaleAged, 80 and overMiddle AgedRetrospective StudiesDatabases, Factual

Stichwörter der Autor:innen

femoral neck fracturefragility fracturehip fractureosteoporosissecondary hip fracture

Substanzen

Bone Density Conservation Agents

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, Georgia.
  • Department of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, North Carolina; Duke Margolis Institute for Health Policy, Durham, North Carolina.
  • Hospital for Special Surgery, New York, New York.

Zitieren

APA

Rieger, E., Fuqua, A., Woltemath, A., Wilson, J. M., Pean, C., Della Valle, A. G., & Premkumar, A. (2026). A Missed Opportunity? Osteoporosis Treatment Following Femoral Neck Fractures: Reducing the Risk of Secondary Hip Fracture. The Journal of Arthroplasty, 41(3), 781-788.e3. https://doi.org/10.1016/j.arth.2025.07.028

Vancouver

Rieger E, Fuqua A, Woltemath A, Wilson JM, Pean C, Della Valle AG, et al. A Missed Opportunity? Osteoporosis Treatment Following Femoral Neck Fractures: Reducing the Risk of Secondary Hip Fracture. The Journal of Arthroplasty. 2026;41(3):781-788.e3. doi:10.1016/j.arth.2025.07.028

BibTeX
@article{Rieger2026,
  author = {Rieger, Elizabeth and Fuqua, Andrew and Woltemath, Alyssa and Wilson, Jacob M and Pean, Christian and Della Valle, Alejandro Gonzalez and Premkumar, Ajay},
  title = {A Missed Opportunity? Osteoporosis Treatment Following Femoral Neck Fractures: Reducing the Risk of Secondary Hip Fracture},
  journal = {The Journal of Arthroplasty},
  year = {2026},
  volume = {41},
  number = {3},
  pages = {781--788.e3},
  doi = {10.1016/j.arth.2025.07.028}
}
Kostenlos starten →